About us
At CUTISS we care
Established in 2017, CUTISS is a Swiss clinical-stage life sciences company focused on regenerative medicine, tissue engineering, and skin pigmentation.
We are a spin-off from University of Zurich (UZH) / University Children’s Hospital, headquartered at the Bio-Technopark in Zurich.
Our subsidiary company CUTISS Innovation is based at Sophia Antipolis in France, and is focused on R&D and innovation in regenerative medicine.
Our team includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
Get to know us
Cutiss we care
Established in 2017, CUTISS is a Swiss clinical-stage life sciences company focused on regenerative medicine, tissue engineering, and skin pigmentation.
We are a spin-off from University of Zurich (UZH) / University Children’s Hospital, headquartered at the Bio-Technopark in Zurich.
Our subsidiary company CUTISS Innovation is based at Sophia Antipolis in France, and is focused on R&D and innovation in regenerative medicine.
Our team includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
Get to know us
About Us
Established in 2017, CUTISS is a Swiss clinical-stage life sciences company focused on regenerative medicine, tissue engineering, and skin pigmentation.
We are a spin-off from University of Zurich (UZH) / University Children’s Hospital, headquartered at the Bio-Technopark in Zurich.
Our subsidiary company CUTISS Innovation is based at Sophia Antipolis in France, and is focused on R&D and innovation in regenerative medicine.
Our team includes scientists, medical doctors, GMP manufacturers, translational researchers and regulatory experts, clinical trial managers, as well as product and business development and industrial expertise.
